Clinical trial
Comparison of High-dose, Short-term Steroid and Low-dose Long-term Steroid Use in ARDS Caused by COVID-19 - Retrospective Cross-sectional Study
NCT05047874 is registered in ClinicalTrials.gov with Biruni University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of High-dose, Short-term Steroid and Low-dose Long-term Steroid Use in ARDS Caused by COVID-19 - Retrospective Cross-sectional Study
- Lead sponsor
- Biruni University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 20, 2021
- Completion date
- October 30, 2021
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
short-term (3 days) high-dose (1000 mg) systemic methylprednisolone